Abstract
The field of nanoultrasonics technology has emerged as a promising avenue for enhancing the diagnosis and treatment of liver cancer, a disease characterized by high mortality rates and complex management challenges. Recent studies highlight the potential of this innovative technology in improving early detection rates and enabling precision therapies, which are crucial for better patient outcomes. Despite these advancements, several issues persist within the realm of clinical application, particularly concerning medical ethics and hospital management practices. This review aims to synthesize the latest research developments in nanoultrasonics technology, focusing on its benefits in liver cancer diagnostics and treatment. Additionally, it will explore the ethical considerations and administrative challenges that arise during its implementation in clinical settings. By addressing these aspects, the review seeks to provide a comprehensive understanding of the current landscape and offer guidance for the standardized application of this technology in the future, ultimately contributing to improved patient care in liver cancer management.